These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23266621)

  • 1. Association of ANRIL polymorphism (rs1333049:C>G) with myocardial infarction and its pharmacogenomic role in hypercholesterolemia.
    Ahmed W; Ali IS; Riaz M; Younas A; Sadeque A; Niazi AK; Niazi SH; Ali SH; Azam M; Qamar R
    Gene; 2013 Feb; 515(2):416-20. PubMed ID: 23266621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin.
    Cerda A; Genvigir FD; Arazi SS; Hirata MH; Dorea EL; Bernik MM; Bertolami MC; Faludi AA; Hirata RD
    Clin Chim Acta; 2010 May; 411(9-10):631-7. PubMed ID: 20064494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia.
    Shabana MF; Mishriki AA; Issac MS; Bakhoum SW
    Mol Diagn Ther; 2013 Oct; 17(5):299-309. PubMed ID: 23677857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANRIL polymorphisms (rs1333049 and rs3217992) in relation to plasma CRP levels among in-patients with CHD.
    Reichert S; Seitter L; Schaller HG; Schlitt A; Schulz S
    Cytokine; 2020 Mar; 127():154932. PubMed ID: 31770616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant.
    Peters BJ; Maitland-van der Zee AH; Stricker BH; van Wieren-de Wijer DB; de Boer A; Kroon AA; de Leeuw PW; Schiffers P; Janssen RG; van Duijn CM; Klungel OH
    Pharmacogenet Genomics; 2008 Jul; 18(7):631-6. PubMed ID: 18551043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin.
    Cerda A; Genvigir FD; Willrich MA; Arazi SS; Bernik MM; Dorea EL; Bertolami MC; Faludi AA; Hirata MH; Hirata RD
    Lipids Health Dis; 2011 Nov; 10():206. PubMed ID: 22074026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia.
    Kajinami K; Brousseau ME; Ordovas JM; Schaefer EJ
    Am J Cardiol; 2004 Jan; 93(1):104-7. PubMed ID: 14697480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of polymorphic variants, rs2267788, rs1333049 and rs2383207 with coronary artery disease, its severity and presentation in North Indian population.
    Kashyap S; Kumar S; Agarwal V; Misra DP; Rai MK; Kapoor A
    Gene; 2018 Mar; 648():89-96. PubMed ID: 29309886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia.
    Rosales A; Alvear M; Cuevas A; Saavedra N; Zambrano T; Salazar LA
    Clin Chim Acta; 2012 Feb; 413(3-4):495-501. PubMed ID: 22120734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent.
    Rodrigues AC; Rebecchi IM; Bertolami MC; Faludi AA; Hirata MH; Hirata RD
    Braz J Med Biol Res; 2005 Sep; 38(9):1389-97. PubMed ID: 16138223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetic predictors of myocardial infarction in subjects of young age].
    Shesternia PA; Nikulina SIu; Shul'man VA; Martynova EA; Demkina AI; Orlov PS; Maksimov VN; Voevoda MI
    Kardiologiia; 2013; 53(7):4-8. PubMed ID: 24087953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCARB1 single nucleotide polymorphism (rs5888) is associated with serum lipid profile and myocardial infarction in an age- and gender-dependent manner.
    Stanislovaitiene D; Lesauskaite V; Zaliuniene D; Smalinskiene A; Gustiene O; Zaliaduonyte-Peksiene D; Tamosiunas A; Luksiene D; Petkeviciene J; Zaliunas R
    Lipids Health Dis; 2013 Mar; 12():24. PubMed ID: 23510561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of lncRNA polymorphisms with triglyceride and total cholesterol levels among myocardial infarction patients in Chinese population.
    Li Y; Zhang D; Zhang Y; Xu X; Bi L; Zhang M; Yu B; Zhang Y
    Gene; 2020 Jan; 724():143684. PubMed ID: 30898706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA ANRIL Expression and ANRIL Gene Polymorphisms Contribute to the Risk of Ischemic Stroke in the Chinese Han Population.
    Yang J; Gu L; Guo X; Huang J; Chen Z; Huang G; Kang Y; Zhang X; Long J; Su L
    Cell Mol Neurobiol; 2018 Aug; 38(6):1253-1269. PubMed ID: 29881905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Myocardial Infarction with CDKN2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 Polymorphism in Slovenian Subjects with Type 2 Diabetes Mellitus.
    Tibaut M; Naji F; Petrovič D
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender-Specific Association Between ABCC2 -24C>T SNP and Reduction in Triglycerides in Chilean Patients Treated With Atorvastatin.
    Prado Y; Arencibia A; Zambrano T; Salazar LA
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):517-522. PubMed ID: 29178257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese.
    Peng WH; Lu L; Zhang Q; Zhang RY; Wang LJ; Yan XX; Chen QJ; Shen WF
    Clin Chem Lab Med; 2009; 47(8):917-22. PubMed ID: 19548844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response.
    Rodrigues AC; Perin PM; Purim SG; Silbiger VN; Genvigir FD; Willrich MA; Arazi SS; Luchessi AD; Hirata MH; Bernik MM; Dorea EL; Santos C; Faludi AA; Bertolami MC; Salas A; Freire A; Lareu MV; Phillips C; Porras-Hurtado L; Fondevila M; Carracedo A; Hirata RD
    Int J Mol Sci; 2011; 12(9):5815-27. PubMed ID: 22016628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
    Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.